Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

BACKGROUND: Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherpereel, Arnaud, Durand-Zaleski, Isabelle, Cotté, François-Emery, Fernandes, Jérôme, Debieuvre, Didier, Blein, Cécile, Gaudin, Anne-Françoise, Tournier, Charlène, Vainchtock, Alexandre, Chauvin, Pierre, Souquet, Pierre-Jean, Westeel, Virginie, Chouaïd, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196460/
https://www.ncbi.nlm.nih.gov/pubmed/30348130
http://dx.doi.org/10.1186/s12885-018-4958-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196460/
https://www.ncbi.nlm.nih.gov/pubmed/30348130
http://dx.doi.org/10.1186/s12885-018-4958-5

Ejemplares similares